Back to Journals » Clinical and Experimental Gastroenterology » Volume 11

A study of the circulating fibroblast growth factor 21 as a novel noninvasive biomarker of hepatic injury in genotype-4 chronic hepatitis C: Egyptian patients and their response to direct-acting antiviral agents

Total article views   HTML views PDF downloads Totals
6,542 Dovepress* 6,261+ 780 7,041
PubMed Central* 281 84 365
Totals 6,542 864 7,406
*Since 24 October 2018

View citations on PubMed Central and Google Scholar